Skip to content
777 Sourcing.

Capability

companion diagnostic development

Suppliers
2
States & provinces
2
Countries
1

2 companion diagnostic development suppliers across 2 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

CANARY ONCOCEUTICS, INC.

FOREST HILLS, NY

Canary Oncoceutics is a cancer diagnostics company developing genomic profiling tests for early detection and personalized treatment guidance. Its tests are CLIA-certified and CAP-Accredited for solid and liquid tumors, analyzing genes to identify mutations for targeted therapy, immunotherapy, and cancer risk assessment. The company also pursues research collaborations and companion diagnostic development.

AI-powered insightsclinical trialscomprehensive gene profilinggenomic profilingliquid biopsy / ctDNA analysis

Compiled from public sources

FOUNDATION MEDICINE, INC.

BOSTON, MA

Foundation Medicine is a global, patient-focused precision medicine company delivering high-quality, transformative diagnostic solutions in cancer and other diseases. Founded in 2010, it developed one of the first standardized comprehensive genomic profiling (CGP) platforms using next-generation sequencing to analyze a broad panel of genes and detect all four classes of genomic alterations. It provides tests and solutions across the patient experience, from diagnosis to treatment selection to ongoing monitoring, and partners with biopharmaceutical compan

AI-enabled toolsassay validationcomprehensive genomic profiling (CGP)IHC testingnext-generation sequencing

Compiled from public sources

Related capabilities

Other processes offered by the shops that list companion diagnostic development.

Browse all capabilities